000811337 001__ 811337
000811337 005__ 20210526125838.0
000811337 0247_ $$2Handle$$a2128/11849
000811337 0247_ $$2ISSN$$a1433-5549
000811337 020__ $$a3-89336-250-9
000811337 037__ $$aFZJ-2016-03825
000811337 041__ $$aEnglish
000811337 1001_ $$0P:(DE-HGF)0$$aCarter, Adrian J.$$b0$$eEditor$$gmale
000811337 245__ $$aCell Culture Models as Alternatives to Animal Experimentation for the Testing of Neuroprotective Compounds in Stroke Research
000811337 260__ $$aJülich$$bForschungszentrum Jülich GmbH Zentralbibliothek, Verlag$$c1999
000811337 300__ $$a145 S.
000811337 3367_ $$2BibTeX$$aBOOK
000811337 3367_ $$0PUB:(DE-HGF)3$$2PUB:(DE-HGF)$$aBook$$bbook$$mbook$$s1468417054_14771
000811337 3367_ $$2DataCite$$aOutput Types/Book
000811337 3367_ $$2ORCID$$aBOOK
000811337 3367_ $$01$$2EndNote$$aBook
000811337 3367_ $$2DRIVER$$abook
000811337 4900_ $$aSchriften des Forschungszentrums Jülich. Reihe Lebenswissenschaften / Life Science$$v3
000811337 520__ $$aThis handbook is the result of a projeet partly financed by the German Ministry for Education, Research, Science and Technlogy (BMBF) which ran for three years from 1995 to 1998 and involved several research groups in Germany. The statement of Lord Adrian, famous for his discovery that the frequency of firing in a nerve cell is a measure of the intensity of the stimulus, quoted above is a way of ethically justifying the use of animals in research. It also contains a very important caveat. It requires us to ask ourselves carefully whether there is really $\textit{no other way}$ of conducting the research in questions. And this is the aim that we have set ourselves for our joint project. During the course of our work wo have developed and relined different cell assay techniques which can be used for investigating the effects of neuroprotective compounds in strake research. We thought it would be worthwhile to share some of the experimental details from our filldings with a wider audience. And we have therefore decided in association with the BMBF to print a handbook which summarizes these methods. But first, why have we chosen human strake as our research target? Thromboembolic stroke causes the death of nerve cells by depriving the brain of an adequate supply of oxygenated blood. The process is called cerebral ischaemia and is primarily a vascular event which leads to damage of brain tissue and impaired function. Strake is the third leading cause of death after coronary heart disease and cancer, and is an importatnt source of adult disability in industrialized nations (Bonita, 1992). Surprisingly, funding of stroke research per death by the National Institutes of Health in the United States falls well behind that of many other of these diseases (NIH, 1998). The brain depends on arterial blood for a continuous supply of oxygen and glucose. Even if blood flow is interrupted for only a few minutes, certain highly vulnerable neurons will degenerate. If the interruption is sustained, then all types of brain cells will eventually die. Fundamental to aur understanding of the pracess of cerebral ischaemia has been the presumption that brain cells do not simply die beeause of energy failure. The link betwecn ischaemia and neuronal death is considerably more complicated. Strake triggers a chain reaction of eleelrieal atld chemieal aetivity which is relatcd 10 ischaemic depolarization, the release of exeitatory amino acids and ehanges in calcium homeostasis (Matlson and Mark, 1996; Tymianski and Tator, 1996). These events act in concert to orchestrate cell death. [...]
000811337 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000811337 7001_ $$0P:(DE-HGF)0$$aKettenmann, Helmut$$b1$$eEditor$$gmale
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.pdf$$yOpenAccess
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.gif?subformat=icon$$xicon$$yOpenAccess
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000811337 8564_ $$uhttps://juser.fz-juelich.de/record/811337/files/Leben_03.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000811337 909CO $$ooai:juser.fz-juelich.de:811337$$pdnbdelivery$$pVDB$$pdriver$$popen_access$$popenaire
000811337 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000811337 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000811337 920__ $$lyes
000811337 9201_ $$0I:(DE-Juel1)PTJ-BIO-20090406$$kPTJ-BIO$$lBiologische Innovation und Ökonomie$$x0
000811337 9801_ $$aFullTexts
000811337 980__ $$abook
000811337 980__ $$aVDB
000811337 980__ $$aI:(DE-Juel1)PTJ-BIO-20090406
000811337 980__ $$aUNRESTRICTED